Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features international roster of speakers.
Posted: 8 June 2015 | Select Biosciences
Select Biosciences is delighted to announce that its Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features all the international key opinion leaders in the organ-on-a-chip/body-on-a-chip field as well as 3D-bioprinting fields…
Select Biosciences is delighted to announce that its Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features all the international key opinion leaders in the organ-on-a-chip/body-on-a-chip field as well as 3D-bioprinting fields.
The 3D-printing field is expanding exponentially and it is starting to impact the life sciences arena. The current interest in this space is the use of various bioinks to “print” parts of tissues in the goal and hope to bioprint organs as well as body parts in the future for regenerative medicine and other medical applications. This conference explores 3D-printing in the life sciences via presentations from academic researchers as well as industry participants. Several companies involved in bioprinting and bioinks will be exhibiting at this conference.
The companion conference track explores Organ-on-a-Chip/Body-on-a-chip which employs the use of microfluidics and lab-on-a-chip (LOAC) technologies to build “cell clusters in 3D-format” in functionally-relevant patterns. These patterns enable cellular function to be recapitulated ex vivo and has wide-ranging potential for drug discovery and development applications in the pharmaceutical and biotechnology industries.
Automation now plays a central role in discovery. From self-driving laboratories to real-time bioprocessing
This report explores how data-driven systems improve reproducibility, speed decisions and make scale achievable across research and development.
Inside the report:
- Advance discovery through miniaturised, high-throughput and animal-free systems
- Integrate AI, robotics and analytics to speed decision-making
- Streamline cell therapy and bioprocess QC for scale and compliance
- And more!
This report unlocks perspectives that show how automation is changing the scale and quality of discovery. The result is faster insight, stronger data and better science – access your free copy today
The conference website for this 2-track event is: http://goo.gl/tcbz9f
For More Information about this Conference, please contact Jeff Fan, Events Manager, Select Biosciences, Inc. Telephone: +1-510-857-4865. E-mail: [email protected]
Related topics
3D printing, Drug Discovery, Organ-on-a-Chip
